Notice of Closed Meeting, 3784-3785 [2019-02165]

Download as PDF 3784 Federal Register / Vol. 84, No. 30 / Wednesday, February 13, 2019 / Notices Mr. Kevin Funk, Procurement Analyst, at telephone 202–357–5805, or email kevin.funk@gsa.gov. FOR FURTHER INFORMATION CONTACT: DEPARTMENT OF DEFENSE GENERAL SERVICES ADMINISTRATION SUPPLEMENTARY INFORMATION: NATIONAL AERONAUTICS AND SPACE ADMINISTRATION A. Purpose [OMB Control No. 9000–0059; Docket No. 2018–0003; Sequence No. 23] Submission for OMB Review; North Carolina Sales Tax Certification Department of Defense (DOD), General Services Administration (GSA), and National Aeronautics and Space Administration (NASA). ACTION: Notice. AGENCY: Under the provisions of the Paperwork Reduction Act, the Regulatory Secretariat Division will be submitting to the Office of Management and Budget (OMB) a request to review and approve an existing OMB emergency clearance notice concerning North Carolina sales tax certification. DATES: Submit comments on or before March 15, 2019. ADDRESSES: Submit comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to: Office of Information and Regulatory Affairs of OMB, Attention: Desk Officer for GSA, Room 10236, NEOB, Washington, DC 20503. Additionally submit a copy to GSA by any of the following methods: • Federal eRulemaking Portal: This website provides the ability to type short comments directly into the comment field or attach a file for lengthier comments. Go to https:// www.regulations.gov and follow the instructions on the site. • Mail: General Services Administration, Regulatory Secretariat Division (MVCB), 1800 F Street NW, Washington, DC 20405. ATTN: Ms. Mandell/IC 9000–0059, North Carolina Sales Tax Certification. Instructions: Please submit comments only and cite Information Collection 9000–0059, North Carolina Sales Tax Certification, in all correspondence related to this collection. Comments received generally will be posted without change to https:// www.regulations.gov, including any personal and/or business confidential information provided. To confirm receipt of your comment(s), please check www.regulations.gov, approximately two to three days after submission to verify posting (except allow 30 days for posting of comments submitted by mail). khammond on DSKBBV9HB2PROD with NOTICES SUMMARY: VerDate Sep<11>2014 17:22 Feb 12, 2019 Jkt 247001 [FR Doc. 2019–02130 Filed 2–12–19; 8:45 am] The Federal Acquisition Regulation (FAR) clause at 52.229–2, North Carolina State and Local Sales and Use Tax, requires contractors for construction or vessel repair to be performed in North Carolina to provide certified statements setting forth the cost of the property purchased from each vendor and the amount of sales or use taxes paid. The North Carolina Sales and Use Tax Act authorizes counties and incorporated cities and towns, to obtain each year from the Commissioner of Revenue of the State of North Carolina, a refund of sales and use taxes indirectly paid on building materials, supplies, fixtures, and equipment that become a part of or are annexed to any building or structure in North Carolina. However, to substantiate a refund claim for sales or use taxes paid on purchases of building materials, supplies, fixtures, or equipment by a contractor, the Government must secure from the contractor certified statements setting forth the cost of the property purchased from each vendor and the amount of sales or use taxes paid. Similar certified statements by subcontractors must be obtained by the general contractor and furnished to the Government. B. Public Comment A 60-day notice published in the Federal Register at 83 FR 51953 on October 15, 2018. No comments were received. C. Annual Reporting Burden The Federal Procurement Data System (FPDS) for 2017 was used to develop the estimated burden hours as shown below: Respondents: 377. Responses per Respondent: 1. Total Annual Responses: 377. Hours per Response: 1.25. Total Burden Hours: 471. Obtaining Copies: Requesters may obtain a copy of the information collection documents from the General Services Administration, Regulatory Secretariat Division (MVCB), 1800 F Street NW, Washington, DC 20405, telephone 202–501–4755. Please cite OMB Control No. 9000–0059, North Carolina Sales Tax Certification, in all correspondence. PO 00000 Frm 00038 Dated: February 7, 2019. Janet Fry, Director, Federal Acquisition Policy Division, Office of Governmentwide Acquisition Policy, Office of Acquisition Policy, Office of Governmentwide Policy. Fmt 4703 Sfmt 4703 BILLING CODE 6820–EP–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended, and the Determination of the Chief Operating Officer, CDC, pursuant to Public Law 92–463. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—RFA–OH–19–001, Occupational Safety and Health National Center for Construction Safety and Health Research and Translation. Dates: May 14, 2019 and May 15, 2019. Time: 6:00 p.m.–7:00 p.m. EDT and 8:30 a.m.–5:00 p.m. EDT. Place: Hilton Embassy Suites, 1900 Diagonal Road, Alexandria, Virginia 22314, (703) 684–5900. Agenda: To review and evaluate grant applications. For Further Information Contact: Michael Goldcamp, Ph.D., Scientific Review Officer, Office of Extramural Programs, CDC, 1095 Willowdale Road, Morgantown, West Virginia 26505, (304) 285–5951; mgoldcamp@cdc.gov. The Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and E:\FR\FM\13FEN1.SGM 13FEN1 Federal Register / Vol. 84, No. 30 / Wednesday, February 13, 2019 / Notices Prevention and the Agency for Toxic Substances and Disease Registry. DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Sherri Berger, Chief Operating Officer, Centers for Disease Control and Prevention. Centers for Disease Control and Prevention Food and Drug Administration Notice of Closed Meeting Authorization of Emergency Use of an In Vitro Diagnostic Device for Detection of Ebola virus; Availability [FR Doc. 2019–02165 Filed 2–12–19; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—Funding Opportunity Announcement (FOA), PAR 16–098, Cooperative Research Agreements to the World Trade Center Health Program (U01); Amended Notice of Meeting khammond on DSKBBV9HB2PROD with NOTICES 3785 Notice is hereby given of a change in the meeting of the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)— Funding Opportunity Announcement (FOA), PAR 16–098, Cooperative Research Agreements to the World Trade Center Health Program (U01); Dates and Times: March 27, 2019, 8:00 a.m.–5:00 p.m., EDT and March 28, 2019, 8:00 a.m.–12:00 p.m., EDT. Hampton Inn & Suites Atlanta Buckhead, 3312 Piedmont Road, Atlanta, Georgia 30305, which was published in the Federal Register on January 31, 2019, Volume 84, Number 21, pages 730. The meeting is being amended to Atlanta Marriott Buckhead Hotel & Conference Center, 3405 Lenox Road NE, Atlanta, GA 30326, Telephone: (404) 261–9250. The meeting is closed to the public. For Further Information Contact: Nina Turner, Ph.D., Scientific Review Officer, CDC/NIOSH, 1095 Willowdale Road, Mailstop L1055, Morgantown, West Virginia 26505, Telephone: (304) 285– 5975, nxt2@cdc.gov. The Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended, and Determination of the Chief Operating Officer, Centers for Disease Control and Prevention, pursuant to Public Law 92–463. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—SIP19–004, Cancer Prevention and Control Research Network Coordinating Center and SIP19–005, Cancer Prevention and Control Research Network Collaborating Center. Dates: April 30, 2019–May 1, 2019. Times: 10:00 a.m.–6:30 p.m., EDT. Place: Teleconference. Agenda: To review and evaluate grant applications. For Further Information Contact: Jaya Raman Ph.D., Scientific Review Officer, CDC, 4770 Buford Highway, Mailstop F80, Atlanta, Georgia 30341, Telephone: (770) 488–6511, kva5@cdc.gov. The Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Sherri Berger, Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2019–02172 Filed 2–12–19; 8:45 am] BILLING CODE 4163–18–P Sherri Berger, Chief Operating Officer, Centers for Disease Control and Prevention. Jkt 247001 Food and Drug Administration, HHS. ACTION: Notice. The Food and Drug Administration (FDA) is announcing the issuance of an Emergency Use Authorization (EUA) (the Authorization) for an in vitro diagnostic device for detection of Ebola virus (species Zaire ebolavirus and hereafter referred to as Ebola virus) in response to the Ebola virus outbreak in the Democratic Republic of the Congo. FDA issued this Authorization under the Federal Food, Drug, and Cosmetic Act (the FD&C Act), as requested by Chembio Diagnostic Systems, Inc. The Authorization contains, among other things, conditions on the emergency use of the authorized in vitro diagnostic device. The Authorization follows the September 22, 2006, determination by then-Secretary of the Department of Homeland Security (DHS), Michael Chertoff, that the Ebola virus presents a material threat against the U.S. population sufficient to affect national security. On the basis of such determination, the Secretary of Health and Human Services (HHS) declared on August 5, 2014, that circumstances exist justifying the authorization of emergency use of in vitro diagnostic devices for detection of Ebola virus, subject to the terms of any authorization issued under the FD&C Act. The Authorization, which includes an explanation of the reasons for issuance, is reprinted in this document. DATES: The Authorization is effective as of November 9, 2018. ADDRESSES: Submit written requests for single copies of the EUA to the Office of Counterterrorism and Emerging Threats, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 1, rm. 4338, Silver Spring, MD 20993– 0002. Send one self-addressed adhesive label to assist that office in processing your request or include a fax number to which the Authorization may be sent. See the SUPPLEMENTARY INFORMATION section for electronic access to the Authorization. SUMMARY: Michael Mair, Office of Counterterrorism and Emerging Threats, BILLING CODE 4163–18–P 17:22 Feb 12, 2019 AGENCY: FOR FURTHER INFORMATION CONTACT: [FR Doc. 2019–02164 Filed 2–12–19; 8:45 am] VerDate Sep<11>2014 [Docket No. FDA–2015–N–0126] PO 00000 Frm 00039 Fmt 4703 Sfmt 4703 E:\FR\FM\13FEN1.SGM 13FEN1

Agencies

[Federal Register Volume 84, Number 30 (Wednesday, February 13, 2019)]
[Notices]
[Pages 3784-3785]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-02165]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended, and the Determination of the Chief Operating 
Officer, CDC, pursuant to Public Law 92-463. The grant applications and 
the discussions could disclose confidential trade secrets or commercial 
property such as patentable material, and personal information 
concerning individuals associated with the grant applications, the 
disclosure of which would constitute a clearly unwarranted invasion of 
personal privacy.

    Name of Committee: Disease, Disability, and Injury Prevention 
and Control Special Emphasis Panel (SEP)--RFA-OH-19-001, 
Occupational Safety and Health National Center for Construction 
Safety and Health Research and Translation.
    Dates: May 14, 2019 and May 15, 2019.
    Time: 6:00 p.m.-7:00 p.m. EDT and 8:30 a.m.-5:00 p.m. EDT.
    Place: Hilton Embassy Suites, 1900 Diagonal Road, Alexandria, 
Virginia 22314, (703) 684-5900.
    Agenda: To review and evaluate grant applications.
    For Further Information Contact: Michael Goldcamp, Ph.D., 
Scientific Review Officer, Office of Extramural Programs, CDC, 1095 
Willowdale Road, Morgantown, West Virginia 26505, (304) 285-5951; 
mgoldcamp@cdc.gov.

    The Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal 
Register notices pertaining to announcements of meetings and other 
committee management activities, for both the Centers for Disease 
Control and

[[Page 3785]]

Prevention and the Agency for Toxic Substances and Disease Registry.

Sherri Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2019-02165 Filed 2-12-19; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.